Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
RESEARCH TOOLSreports
Circassia Pharmaceuticals (NIOX) Share Price & Analysis
6 Followers
NIOX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range51.31p - 74.56p
Previous Close70p
Volume7.74M
Average Volume (3M)1.10M
Market Cap
£296.44M
Enterprise Value277.64M
Total Cash (Recent Filing)£19.90M
Total Debt (Recent Filing)£1.10M
Price to Earnings (P/E)29.2
Beta0.58
Next Earnings
Sep 25, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding422,120,630
10 Day Avg. Volume1,407,061
30 Day Avg. Volume1,098,918
Standard Deviation0.19
R-Squared0.07
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.79
Price to Sales (P/S)288.77
Price to Cash Flow (P/CF)22.40
P/FCF Ratio22.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
250.00pPrice Target Upside257.14% Upside
Rating ConsensusHold
Number of Analyst Covering1
Circassia Pharmaceuticals News
PremiumCompany Announcements
Stakeholder Reduces Share in NIOX Group plc
PremiumCompany Announcements
Circassia Pharmaceuticals’ AGM Resolutions Approved
PremiumCompany Announcements
NIOX Group Reports Strong Performance and Growth
PremiumCompany Announcements
Circassia Pharmaceuticals Announces Share Capital Update
PremiumCompany Announcements
Circassia Pharmaceuticals Launches Employee Share SchemeOptions Prices
Currently, No data available
---
Ownership Overview
3.05% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
96.93% Public Companies and
Individual Investors
NIOX FAQ
What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?
Circassia Pharmaceuticals PLC lowest share price was 51.30p and its highest was 74.56p in the past 12 months.
What is Circassia Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?
Circassia Pharmaceuticals PLC’s upcoming earnings report date is Sep 25, 2024 which is in 120 days.
How were Circassia Pharmaceuticals PLC’s earnings last quarter?
Circassia Pharmaceuticals PLC released its earnings results on Mar 26, 2024. The company reported 0.017p earnings per share for the quarter, beating the consensus estimate of N/A by 0.017p.
Is Circassia Pharmaceuticals PLC overvalued?
According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Undervalued.
Does Circassia Pharmaceuticals PLC pay dividends?
Circassia Pharmaceuticals PLC pays a Notavailable dividend of 1p which represents an annual dividend yield of N/A. See more information on Circassia Pharmaceuticals PLC dividends here
What is Circassia Pharmaceuticals PLC’s EPS estimate?
Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Circassia Pharmaceuticals PLC have?
Circassia Pharmaceuticals PLC has 424,045,470 shares outstanding.
What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?
Circassia Pharmaceuticals PLC reported an EPS of 0.017p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.923%.
Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:NIOX
---
Circassia Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
250.00p (257.14% Upside)
250.00p (257.14% Upside)
Insider Transactions
Sold Shares
Worth £398.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.25%
12-Months-Change
Fundamentals
Return on Equity
11.47%
Trailing 12-Months
Asset Growth
-7.11%
Trailing 12-Months
Company Description
Circassia Pharmaceuticals PLC
Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.
---
NIOX Stock 12 Month Forecast
Average Price Target
250.00p
▲(257.14% Upside)
Technical Analysis
GlaxoSmithKline
―
Abingdon Health PLC
―
EKF Diagnostics Holdings
―
Futura Medical
―
Best Analysts Covering NIOX
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 8 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---